Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055031) titled 'Efficacy of Biofeedback Therapy in the Treatment of Dysfunctional Voiding' on Aug. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Furkan Adem Canbaz
Condition:
Condition - The aim of the study is to detect the efficacy of biofeedback and to show the effect of overactive bladder on treatment
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To determine the efficacy of biofeedback therapy for the treatment of dysfunctional voiding in children.
To show effect of overactive bladder on the treatment success of biofeedback therapy.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 5
years-old
Gender - Male and Female
Key inclusion criteria - To have the diagnosis of dysfunctional voiding
To complete BF sessions
Key exclusion criteria - Presence of anatomical or neurological problems
Target Size - 35
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2022 Year 09 Month 01 Day
Anticipated trial start date - 2022 Year 09 Month 01 Day
Last follow-up date - 2024 Year 06 Month 29 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062869
Disclaimer: Curated by HT Syndication.
